In 2001, the decoding of the human genome sparked a revolution in how we understand human health and disease. Three years later, the Broad Institute of MIT and Harvard was founded to fulfill the promise of this revolution: to reveal the fundamental basis of disease and catalyze rational treatments.
Based in the dynamic biomedical hub of Kendall Square, Cambridge, the Broad brings together an extraordinary community of scientists from MIT, Harvard, and the five Harvard teaching hospitals. We believe the toughest challenges in biomedicine require new institutions that are:
CollaborativeSpanning across nations, research institutions and scientific disciplines, and academia and industry.
NimbleAble to move quickly and mount projects at any scale—from a single laboratory to an industry-style team.
BoldWilling to tackle high-risk, high-reward projects.
OpenCommitted to sharing tools, methods, and data with the entire scientific community.
The Broad embodies this new model. Equipped with world-leading technology and unrivaled scientific platforms, our scientists are narrowing the gap between biological insight and clinical impact, paving the way for novel therapeutics for a wide range of human diseases.